Incyte (INCY) Interest & Investment Income (2010 - 2026)
Incyte (INCY) posted Interest & Investment Income of $33.7 million for Q1 2026, up 9.54% on a QoQ basis from $30.8 million in Q4 2025, and up 46.92% year-over-year from $22.9 million in Q1 2025.
Incyte (INCY) Interest & Investment Income (2010 - 2026) Analysis & Trends
Incyte's Interest & Investment Income history runs 11 years deep, the most recent figure standing at $33.7 million for Q1 2026.
- Quarterly Interest & Investment Income rose 46.92% year-over-year to $33.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $116.4 million (up 10.96% YoY) and the FY2025 annual result came in at $105.6 million, down 17.96% from the prior year.
- Interest & Investment Income was $33.7 million for Q1 2026 at Incyte, up from $30.8 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $46.8 million in Q1 2024 and bottomed at $19.3 million in Q3 2024.
- A 3-year average of $29.8 million and a median of $26.8 million in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income sank 50.97% — and 2026, when it soared 46.92%.
- Incyte's Interest & Investment Income stood at $21.2 million in 2024, then jumped by 45.08% to $30.8 million in 2025, then climbed by 9.54% to $33.7 million in 2026.
- Business Quant data shows INCY's Interest & Investment Income at $33.7 million in Q1 2026, $30.8 million in Q4 2025, and $26.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Incyte | 23.64 Bn | 19.62 Bn | 1.17 Bn | 33.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.69 Mn |
| Dec 31, 2025 | 30.75 Mn |
| Sep 30, 2025 | 26.78 Mn |
| Jun 30, 2025 | 25.14 Mn |
| Mar 31, 2025 | 22.93 Mn |
| Dec 31, 2024 | 21.20 Mn |
| Sep 30, 2024 | 19.27 Mn |
| Jun 30, 2024 | 41.48 Mn |
| Mar 31, 2024 | 46.77 Mn |
| Dec 31, 2017 | 6.27 Mn |
| Sep 30, 2017 | 5.56 Mn |
| Jun 30, 2017 | 4.13 Mn |
| Mar 31, 2017 | 1.20 Mn |
| Dec 31, 2016 | 594,000.00 |
| Sep 30, 2016 | 1.19 Mn |
| Jun 30, 2016 | 1.14 Mn |
| Mar 31, 2016 | 1.49 Mn |
| Dec 31, 2015 | 1.29 Mn |
| Sep 30, 2015 | 3.03 Mn |
| Jun 30, 2015 | 1.14 Mn |